Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
7.00
-0.21 (-2.91%)
Jan 20, 2026, 4:00 PM EST - Market closed

Champions Oncology Statistics

Total Valuation

CSBR has a market cap or net worth of $97.20 million. The enterprise value is $94.10 million.

Market Cap97.20M
Enterprise Value 94.10M

Important Dates

The next estimated earnings date is Tuesday, March 10, 2026, after market close.

Earnings Date Mar 10, 2026
Ex-Dividend Date n/a

Share Statistics

CSBR has 13.89 million shares outstanding. The number of shares has increased by 4.06% in one year.

Current Share Class 13.89M
Shares Outstanding 13.89M
Shares Change (YoY) +4.06%
Shares Change (QoQ) +4.85%
Owned by Insiders (%) 26.50%
Owned by Institutions (%) 11.18%
Float 5.19M

Valuation Ratios

The trailing PE ratio is 40.11 and the forward PE ratio is 140.00.

PE Ratio 40.11
Forward PE 140.00
PS Ratio 1.65
Forward PS 1.56
PB Ratio 23.31
P/TBV Ratio 25.35
P/FCF Ratio 17.23
P/OCF Ratio 15.62
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.70, with an EV/FCF ratio of 16.68.

EV / Earnings 37.78
EV / Sales 1.61
EV / EBITDA 23.70
EV / EBIT 38.21
EV / FCF 16.68

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 1.28.

Current Ratio 0.96
Quick Ratio 0.91
Debt / Equity 1.28
Debt / EBITDA 0.94
Debt / FCF 0.96
Interest Coverage 91.22

Financial Efficiency

Return on equity (ROE) is 98.94% and return on invested capital (ROIC) is 18.01%.

Return on Equity (ROE) 98.94%
Return on Assets (ROA) 5.56%
Return on Invested Capital (ROIC) 18.01%
Return on Capital Employed (ROCE) 30.71%
Revenue Per Employee $274,291
Profits Per Employee $11,695
Employee Count213
Asset Turnover 2.11
Inventory Turnover n/a

Taxes

Income Tax -73,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.43% in the last 52 weeks. The beta is 0.36, so CSBR's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -28.43%
50-Day Moving Average 6.73
200-Day Moving Average 6.90
Relative Strength Index (RSI) 53.19
Average Volume (20 Days) 7,749

Short Selling Information

The latest short interest is 77,421, so 0.56% of the outstanding shares have been sold short.

Short Interest 77,421
Short Previous Month 80,631
Short % of Shares Out 0.56%
Short % of Float 1.49%
Short Ratio (days to cover) 3.44

Income Statement

In the last 12 months, CSBR had revenue of $58.42 million and earned $2.49 million in profits. Earnings per share was $0.17.

Revenue58.42M
Gross Profit 29.28M
Operating Income 2.46M
Pretax Income 2.36M
Net Income 2.49M
EBITDA 3.97M
EBIT 2.46M
Earnings Per Share (EPS) $0.17
Full Income Statement

Balance Sheet

The company has $8.52 million in cash and $5.41 million in debt, with a net cash position of $3.10 million or $0.22 per share.

Cash & Cash Equivalents 8.52M
Total Debt 5.41M
Net Cash 3.10M
Net Cash Per Share $0.22
Equity (Book Value) 4.23M
Book Value Per Share 0.30
Working Capital -809,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $6.22 million and capital expenditures -$583,000, giving a free cash flow of $5.64 million.

Operating Cash Flow 6.22M
Capital Expenditures -583,000
Free Cash Flow 5.64M
FCF Per Share $0.41
Full Cash Flow Statement

Margins

Gross margin is 50.11%, with operating and profit margins of 4.22% and 4.26%.

Gross Margin 50.11%
Operating Margin 4.22%
Pretax Margin 4.03%
Profit Margin 4.26%
EBITDA Margin 6.80%
EBIT Margin 4.22%
FCF Margin 9.65%

Dividends & Yields

CSBR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.06%
Shareholder Yield -4.06%
Earnings Yield 2.56%
FCF Yield 5.80%

Analyst Forecast

The average price target for CSBR is $12.00, which is 71.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 71.43%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 18.59%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.

Last Split Date Aug 12, 2015
Split Type Reverse
Split Ratio 1:12

Scores

CSBR has an Altman Z-Score of 0.83 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.83
Piotroski F-Score 7